Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan · Delayed Price · Currency is JPY 4,650.00
-40.00 (-0.85%)
Jan 21, 2026, 3:30 PM JST
Kissei Pharmaceutical Revenue
Kissei Pharmaceutical had revenue of 23.64B JPY in the quarter ending September 30, 2025, with 10.98% growth. This brings the company's revenue in the last twelve months to 91.70B, up 13.11% year-over-year. In the fiscal year ending March 31, 2025, Kissei Pharmaceutical had annual revenue of 88.33B with 16.87% growth.
Revenue (ttm)
91.70B
Revenue Growth
+13.11%
P/S Ratio
2.10
Revenue / Employee
51.57M
Employees
1,778
Market Cap
192.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 88.33B | 12.75B | 16.87% |
| Mar 31, 2024 | 75.58B | 8.09B | 11.98% |
| Mar 31, 2023 | 67.49B | 2.11B | 3.23% |
| Mar 31, 2022 | 65.38B | -3.66B | -5.31% |
| Mar 31, 2021 | 69.04B | 5.81B | 9.19% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |
Kissei Pharmaceutical News
- 9 months ago - Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - Benzinga